Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position Remove CMDh final position filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes (8) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 20 procedures Remove Article 20 procedures filter Article 31 referrals (120) Apply Article 31 referrals filter Article 30 referrals (94) Apply Article 30 referrals filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 107i procedures (9) Apply Article 107i procedures filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (19) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (24) Apply Centrally authorised product(s) filter Nationally authorised product(s) (14) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (14) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (4) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (3) Apply Conditional approval filter Orphan medicine (1) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

147 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter

Referral type Article 20 procedures Remove Article 20 procedures filter Article 29(4) referrals Remove Article 29(4) referrals filter

Referral status CMDh final position Remove CMDh final position filter European Commission final decision Remove European Commission final decision filter

Categories Human Remove Human filter

Sort by

List item

Referral: Oracea

doxycycline monohydrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 22/07/2008, Last updated: 21/08/2008
List item

Referral: Levact

bendamustine, associated names: Ribomustin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 07/07/2010, Last updated: 08/09/2011
List item

Referral: Adartrel

ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006
List item

Referral: Lisonorm

lisinopril, amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2008, EC decision date: 12/11/2008, Last updated: 18/12/2008
List item

Referral: Sanohex

salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009
List item

Referral: Lansoprazol HEXAL 15 mg and 30 mg

Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 15/09/2005, Last updated: 15/09/2005
List item

Referral: Mifepristone Linepharma

mifepristone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 11/09/2012, Last updated: 03/01/2013
List item

Referral: Octegra

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 02/10/2009, Last updated: 25/06/2009
List item

Referral: Ethirfin

morphine sulphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 20/12/2010, Last updated: 29/04/2011
List item

Referral: Myderison

tolperisone hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 06/08/2010, Last updated: 16/06/2011
List item

Referral: Glimepirida Parke-Davis

glimepiride, associated names: Glimepiride Pfizer, Glimepirid Pfizer, Glimepiride tablets 2 mg, Glimepiride tablets 3 mg, Glimepiride tablets 4 mg, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 19/11/2012, Last updated: 06/12/2012
List item

Referral: Amaryl

glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998
List item

Referral: Pantoprazole Bluefish

pantoprazole, associated names: Pantecta, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 30/03/2010, Last updated: 09/03/2011
List item

Referral: Corlentor and Procoralan

ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015
List item

Referral: Valebo and associated names

alendronic acid, alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, Last updated: 31/03/2014
List item

Referral: Merisone and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Flutiform

fluticasone propionate, formoterol fumarate, associated names: Iffeza, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012
List item

Referral: Activelle

estradiol, norethisterone acetate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2008
List item

Referral: Doxagamma 4mg

Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006
List item

Referral: Zinbryta

associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018, Last updated: 11/07/2018
List item

Referral: Lansoprazole

Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 18/09/2007, Last updated: 14/12/2007
List item

Referral: Dexamed and associated names

dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 02/09/2014
List item

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

bivalent HPV vaccine (types 16, 18), quadrivalent HPV vaccine (types 6, 11, 16, 18), 9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58), associated names: Cervarix, Gardasil, Gardasil 9, Silgard, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/11/2015, EC decision date: 12/01/2016, Last updated: 20/01/2016
List item

Referral: Doxazosin "Winthrop" 4mg

Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006

Load more

147 results

Referral: Oracea

Referral: Levact

Referral: Adartrel

Referral: Lisonorm

Referral: Sanohex

Referral: Lansoprazol HEXAL 15 mg and 30 mg

Referral: Mifepristone Linepharma

Referral: Octegra

Referral: Ethirfin

Referral: Myderison

Referral: Glimepirida Parke-Davis

Referral: Amaryl

Referral: Pantoprazole Bluefish

Referral: Corlentor and Procoralan

Referral: Valebo and associated names

Referral: Merisone and associated names

Referral: Avalox

Referral: Flutiform

Referral: Activelle

Referral: Doxagamma 4mg

Referral: Zinbryta

Referral: Lansoprazole

Referral: Dexamed and associated names

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Referral: Doxazosin "Winthrop" 4mg